Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.

A careful and accurate supportive care is essential to mitigate EDP-M side effects as much as possible and avoid that, due to toxicity, patients have to reduce doses and or postpone cytotoxic treatment with a negative impact on efficacy of this chemotherapy regimen.